PAPER Tan EK, Wu YR

Author response.

Neurology. 2014 Feb 4;82(5):461. PubMed: 24649492

PAPER Suwijn SR, Berendse HW, Verschuur CV, de Bie RM, Booij J

Serotonin transporter availability in early stage Parkinson's disease and multiple system atrophy.

ISRN Neurol. 2014;2014:345132. Epub 2014 Feb 3 PubMed: 24693450

PAPER Chatterjee P, Bhattacharyya M, Bandyopadhyay S, Roy D

Studying the system-level involvement of microRNAs in Parkinson's disease.

PLoS One. 2014;9(4):e93751. Epub 2014 Apr 1 PubMed: 24690883

PAPER Chandrasekaran S, Bonchev D

A network view on Parkinson's disease.

Comput Struct Biotechnol J. 2013;7:e201304004. Epub 2013 Jul 14 PubMed: 24688734

PAPER Lladó A, Grau-Rivera O, Sánchez-Valle R, Balasa M, Obach V, Amaro S, Rey MJ, Molinuevo JL, Gelpi E, Antonell A

Large APP locus duplication in a sporadic case of cerebral haemorrhage.

Neurogenetics. 2014 May;15(2):145-9. Epub 2014 Apr 2 PubMed: 24691562

PAPER Stegmüller J, Bonni A

Moving past proliferation: new roles for Cdh1-APC in postmitotic neurons.

Trends Neurosci. 2005 Nov;28(11):596-601. Epub 2005 Sep 15 PubMed: 16168498

PAPER Beach TG, Walker DG, Roher AE, Potter PE

Anti-Amyloidogenic Activity of Cholinergic Agents

Drug Dev Res. 2002;56 (2):242-47.

Noha Saad

Tom Dresselaers

Biomedical MRI/ MoSAIC KU Leuven
Leuven, Belgium

Herbert Noack

Boehringer-Ingelheim
Ingelheim, Germany

Yasmine Said

Charite University
berlin, Germany

Laura Pulford

UCL

Shuoshuo Li

Science of Llife Academic

Daishi Yui

Tokyo Medical and Dental University
Bunkyo, Japan

Susan Landau on PBT2 Takes a Dive in Phase 2 Alzheimer’s Trial

COMMENT Our group has been working on longitudinal amyloid PET measurements recently, and there are a number of methodological challenges. Measuring longitudinal amyloid PET is new territory, and there is not yet a clear answer about the best way to do it. The fi